133 related articles for article (PubMed ID: 10471064)
1. Low frequency of CYP2A6 gene polymorphism as revealed by a one-step polymerase chain reaction method.
Chen GF; Tang YM; Green B; Lin DX; Guengerich FP; Daly AK; Caporaso NE; Kadlubar FF
Pharmacogenetics; 1999 Jun; 9(3):327-32. PubMed ID: 10471064
[TBL] [Abstract][Full Text] [Related]
2. Comparison of cytochrome P450 2A6 polymorphism frequencies in Caucasians and African-Americans using a new one-step PCR-RFLP genotyping method.
Paschke T; Riefler M; Schuler-Metz A; Wolz L; Scherer G; McBride CM; Bepler G
Toxicology; 2001 Nov; 168(3):259-68. PubMed ID: 11684323
[TBL] [Abstract][Full Text] [Related]
3. A genetic polymorphism in coumarin 7-hydroxylation: sequence of the human CYP2A genes and identification of variant CYP2A6 alleles.
Fernandez-Salguero P; Hoffman SM; Cholerton S; Mohrenweiser H; Raunio H; Rautio A; Pelkonen O; Huang JD; Evans WE; Idle JR
Am J Hum Genet; 1995 Sep; 57(3):651-60. PubMed ID: 7668294
[TBL] [Abstract][Full Text] [Related]
4. CYP2A6 genetic polymorphisms and liver microsomal coumarin and nicotine oxidation activities in Japanese and Caucasians.
Inoue K; Yamazaki H; Shimada T
Arch Toxicol; 2000 Jan; 73(10-11):532-9. PubMed ID: 10663384
[TBL] [Abstract][Full Text] [Related]
5. Characterisation and PCR-based detection of a CYP2A6 gene deletion found at a high frequency in a Chinese population.
Oscarson M; McLellan RA; Gullstén H; Yue QY; Lang MA; Bernal ML; Sinues B; Hirvonen A; Raunio H; Pelkonen O; Ingelman-Sundberg M
FEBS Lett; 1999 Apr; 448(1):105-10. PubMed ID: 10217419
[TBL] [Abstract][Full Text] [Related]
6. Determination of coumarin metabolism in Turkish population.
Cok I; Aygün Kocabaş N; Cholerton S; Karakaya AE; Sardaş S
Hum Exp Toxicol; 2001 Apr; 20(4):179-84. PubMed ID: 11393269
[TBL] [Abstract][Full Text] [Related]
7. Functional variants at CYP2A6: new genotyping methods, population genetics, and relevance to studies of tobacco dependence.
Zabetian CP; Gelernter J; Cubells JF
Am J Med Genet; 2000 Oct; 96(5):638-45. PubMed ID: 11054771
[TBL] [Abstract][Full Text] [Related]
8. Homologous unequal cross-over within the human CYP2A gene cluster as a mechanism for the deletion of the entire CYP2A6 gene associated with the poor metabolizer phenotype.
Nunoya K; Yokoi T; Takahashi Y; Kimura K; Kinoshita M; Kamataki T
J Biochem; 1999 Aug; 126(2):402-7. PubMed ID: 10423536
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphisms of cytochrome P450 2A6 in a case-control study on lung cancer in a French population.
Loriot MA; Rebuissou S; Oscarson M; Cenée S; Miyamoto M; Ariyoshi N; Kamataki T; Hémon D; Beaune P; Stücker I
Pharmacogenetics; 2001 Feb; 11(1):39-44. PubMed ID: 11207029
[TBL] [Abstract][Full Text] [Related]
10. Nicotine metabolism and CYP2A6 allele frequencies in Koreans.
Kwon JT; Nakajima M; Chai S; Yom YK; Kim HK; Yamazaki H; Sohn DR; Yamamoto T; Kuroiwa Y; Yokoi T
Pharmacogenetics; 2001 Jun; 11(4):317-23. PubMed ID: 11434509
[TBL] [Abstract][Full Text] [Related]
11. A new deleted allele in the human cytochrome P450 2A6 (CYP2A6) gene found in individuals showing poor metabolic capacity to coumarin and (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride (SM-12502).
Nunoya K; Yokoi T; Kimura K; Inoue K; Kodama T; Funayama M; Nagashima K; Funae Y; Green C; Kinoshita M; Kamataki T
Pharmacogenetics; 1998 Jun; 8(3):239-49. PubMed ID: 9682269
[TBL] [Abstract][Full Text] [Related]
12. CYP2A7 polymorphic alleles confound the genotyping of CYP2A6*4A allele.
Fukami T; Nakajima M; Sakai H; McLeod HL; Yokoi T
Pharmacogenomics J; 2006; 6(6):401-12. PubMed ID: 16636685
[TBL] [Abstract][Full Text] [Related]
13. Novel human CYP2A6 alleles confound gene deletion analysis.
Nakajima M; Yoshida R; Fukami T; McLeod HL; Yokoi T
FEBS Lett; 2004 Jul; 569(1-3):75-81. PubMed ID: 15225612
[TBL] [Abstract][Full Text] [Related]
14. Three haplotypes associated with CYP2A6 phenotypes in Caucasians.
Haberl M; Anwald B; Klein K; Weil R; Fuss C; Gepdiremen A; Zanger UM; Meyer UA; Wojnowski L
Pharmacogenet Genomics; 2005 Sep; 15(9):609-24. PubMed ID: 16041240
[TBL] [Abstract][Full Text] [Related]
15. A novel single nucleotide polymorphism altering stability and activity of CYP2a6.
Ariyoshi N; Sawamura Y; Kamataki T
Biochem Biophys Res Commun; 2001 Mar; 281(3):810-4. PubMed ID: 11237731
[TBL] [Abstract][Full Text] [Related]
16. Frequency of CYP2A6 gene deletion and its relation to risk of lung and esophageal cancer in the Chinese population.
Tan W; Chen GF; Xing DY; Song CY; Kadlubar FF; Lin DX
Int J Cancer; 2001 Mar; 95(2):96-101. PubMed ID: 11241319
[TBL] [Abstract][Full Text] [Related]
17. High prevalence of cytochrome P450 2A6*1A alleles in a black African population of Ghana.
Gyamfi MA; Fujieda M; Kiyotani K; Yamazaki H; Kamataki T
Eur J Clin Pharmacol; 2005 Feb; 60(12):855-7. PubMed ID: 15660270
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterisation of novel polymorphisms in the CYP2A locus: implications for nicotine metabolism.
Oscarson M; McLellan RA; Gullstén H; Agúndez JA; Benítez J; Rautio A; Raunio H; Pelkonen O; Ingelman-Sundberg M
FEBS Lett; 1999 Oct; 460(2):321-7. PubMed ID: 10544257
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a novel CYP2A7/CYP2A6 hybrid allele (CYP2A6*12) that causes reduced CYP2A6 activity.
Oscarson M; McLellan RA; Asp V; Ledesma M; Bernal Ruiz ML; Sinues B; Rautio A; Ingelman-Sundberg M
Hum Mutat; 2002 Oct; 20(4):275-83. PubMed ID: 12325023
[TBL] [Abstract][Full Text] [Related]
20. A novel polymorphism of human CYP2A6 gene CYP2A6*17 has an amino acid substitution (V365M) that decreases enzymatic activity in vitro and in vivo.
Fukami T; Nakajima M; Yoshida R; Tsuchiya Y; Fujiki Y; Katoh M; McLeod HL; Yokoi T
Clin Pharmacol Ther; 2004 Dec; 76(6):519-27. PubMed ID: 15592323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
